Recent federal approval of two nonprescription naloxone nasal sprays to reverse opioid overdoses was a pivotal part of the National Safety Council’s (NSC) ambitious effort to reduce drug-related challenges at work. Lorraine M. Martin, NSC’s president and CEO, is now on a mission to offer the nasal sprays Narcan and RiVive to as many properly trained employees as possible in workplaces and beyond. This is critical to help stem the ongoing rise in drug-related deaths, especially those involving fentanyl, the potent synthetic opioid known for being up to 50 times stronger than heroin and 100 times stronger than morphine. “I urge all workplaces to carry naloxone in their first… Read More